McCollum Christoferson Group LLC Has $2.19 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

McCollum Christoferson Group LLC reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 2.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,098 shares of the company’s stock after selling 528 shares during the period. McCollum Christoferson Group LLC’s holdings in Colgate-Palmolive were worth $2,190,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Diversify Advisory Services LLC bought a new stake in shares of Colgate-Palmolive during the 1st quarter valued at approximately $911,000. TD Asset Management Inc increased its holdings in shares of Colgate-Palmolive by 2.4% during the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock worth $103,969,000 after buying an additional 26,987 shares in the last quarter. Empowered Funds LLC lifted its stake in shares of Colgate-Palmolive by 277.3% in the 1st quarter. Empowered Funds LLC now owns 33,082 shares of the company’s stock valued at $2,979,000 after acquiring an additional 24,314 shares during the last quarter. M&G Plc acquired a new stake in shares of Colgate-Palmolive during the 1st quarter valued at $3,812,000. Finally, Sei Investments Co. grew its position in Colgate-Palmolive by 41.5% during the 1st quarter. Sei Investments Co. now owns 598,639 shares of the company’s stock worth $53,901,000 after acquiring an additional 175,445 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on CL. BNP Paribas began coverage on Colgate-Palmolive in a report on Monday, June 24th. They set an “outperform” rating and a $109.00 price target on the stock. Hsbc Global Res downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Citigroup lifted their price target on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Sanford C. Bernstein upped their price target on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. Finally, Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their target price for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $106.00.

Colgate-Palmolive Trading Down 0.3 %

NYSE CL opened at $101.20 on Thursday. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90. The firm has a market capitalization of $83.03 billion, a P/E ratio of 32.03, a PEG ratio of 3.54 and a beta of 0.40. The business has a fifty day simple moving average of $103.51 and a 200 day simple moving average of $97.44. Colgate-Palmolive has a 12 month low of $71.22 and a 12 month high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same quarter in the prior year, the company posted $0.77 earnings per share. The firm’s revenue for the quarter was up 4.9% on a year-over-year basis. On average, analysts predict that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.98%. Colgate-Palmolive’s payout ratio is presently 63.29%.

Insider Activity

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, EVP Gregory Malcolm sold 10,533 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the sale, the executive vice president now owns 10,377 shares in the company, valued at $1,069,868.70. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock valued at $4,486,063 over the last three months. Corporate insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.